在中与双基突变相关的遗传视网膜疾病患者的基因增强疗法的长期经验
1c/o Justus-Liebig-University Giessen TransMIT Centre of Translational Ophthalmology Am Galgenberg 37 35321 Laubach Germany.
概括
与RPE65突变相关的遗传视网膜退化 (IRD) 的基因治疗显示了持续的棒功能改善. 然而,加速胆管缩是一个新发现的风险,需要进一步研究.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 视网膜疾病 视网膜疾病
背景情况:
- 遗传性视网膜退化 (IRD) 由于RPE65双基突变是唯一批准基因治疗的IRD.
- 沃雷特基因 neparvovec (LuxturnaTM) 在美国 (2017) 和欧洲 (2018) 获得了监管批准.
研究的目的:
- 审查疾病,并更新文献的结果后voretigene neparvovec批准.
- 评估RPE65-IRD的基因增强疗法的营销后结果.
主要方法:
- 对当前文学进行叙述性回顾.
- 对营销后数据和临床试验结果的分析.
- 评估特定的功能测试,如全场色彩光敏感性测试.
主要成果:
- 市场营销后的数据证实了与临床试验相一致的对杆功能显著的治疗效果.
- 全场色彩光敏感性测试有效地证明了早期和持续的治疗效果.
- 在早期疾病中,视觉敏度和视野可能会改善.
- 加快胆管缩 (CRA) 是一种新发现的不良影响,在13-50%的接受治疗的眼睛中,可能导致视力丧失.
结论:
- 沃雷特基因基因疗法对RPE65-IRD提供了显著的好处,特别是在棒功能方面.
- 加快胆管缩是一个关键的不良事件,需要进一步调查.
- 识别患有CRA风险的患者对于优化这种基因治疗的好处至关重要.
更多相关视频
07:43Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
1.9K
07:13An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
13.1K
相关概念视频
Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
